IONIS PHARMACEUTICALS INC (IONS) Stock Analyst Ratings
USA - NASDAQ:IONS - US4622221004 - Common Stock
62.97 USD
-0.97 (-1.52%)
62.97 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 71.85. This target is 14.1% above the current price.
IONS was analyzed by 33 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-02 | Needham | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-25 | Needham | Reiterate | Buy -> Buy |
| 2025-08-25 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-08-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-22 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-22 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-31 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-07-31 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-07-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-01 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-05-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |